AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. The company offers sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also provides wheelchairs, hospital beds, oxygen concentrators, insulin pumps, CPAP masks and related supplies, diabetes management and wound care supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Plymouth Meeting, Pennsylvania.
Diabetes Dilemma | AdaptHealth grapples with challenges in its diabetes segment, implementing corrective measures amid signs of improvement in the secto |
Market Dynamics | Explore AdaptHealth's strategies to reclaim market share and navigate industry-wide multiple compression affecting healthcare equipment valuations |
Financial Resilience | Delve into AdaptHealth's profitability and strong free cash flow yield, with analyst price targets ranging from $9.50 to $16.00 |
Strategic Outlook | Learn how AdaptHealth's management initiatives and minimal tariff impact position the company for potential growth in home healthcare solutions |
Metrics to compare | AHCO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAHCOPeersSector | |
---|---|---|---|---|
P/E Ratio | 17.8x | −0.1x | −0.5x | |
PEG Ratio | 0.15 | 0.10 | 0.00 | |
Price/Book | 0.8x | 1.0x | 2.6x | |
Price / LTM Sales | 0.4x | 1.1x | 3.3x | |
Upside (Analyst Target) | 28.6% | 77.8% | 42.8% | |
Fair Value Upside | Unlock | 19.6% | 6.5% | Unlock |